Literature DB >> 2518867

Effects of cisapride on ano-rectal sphincter function.

P Enck1, H G Arping, S Engel, K Bielefeldt, J F Erckenbrecht.   

Abstract

To investigate the effects of cisapride, a motility-inducing agent, on ano-rectal sphincter functions, standard manometry was performed in 10 healthy male volunteers after 5 days on a 20-mg dose of cisapride in a placebo-controlled double-blind randomized crossover fashion. All subjects kept stool diaries during the experiment. Cisapride significantly increased stool frequency by adding soft and liquid stools; in addition, anal resting pressure was reduced with cisapride in seven of the 10 subjects; mean resting pressure decreased by 16%, while all other measurements were not altered. This suggests that cisapride may act directly on the smooth muscle of the internal anal sphincter. It also supports the view that enhanced defaecation in chronic constipation induced by cisapride may not be achieved by propulsive motor activity in the colon but also by a decreased anal sphincter tone.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2518867     DOI: 10.1111/j.1365-2036.1989.tb00245.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  4 in total

Review 1.  Mediation, muscle receptors, neurotransmitters, and drugs. Frontiers in gastric emptying.

Authors:  P Enck; L Bueno; F Froehlich
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

2.  Effect of 5-HT1 agonist (sumatriptan) on anorectal function in irritable bowel syndrome patients.

Authors:  Agata Mulak; Leszek Paradowski
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

Review 3.  A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders.

Authors:  J Tack; G Coremans; J Janssens
Journal:  Drug Saf       Date:  1995-06       Impact factor: 5.606

Review 4.  Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.

Authors:  L R Wiseman; D Faulds
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.